戻る
Akeso, Inc. (AKESF)価格
AKESF 株価推移チャート
AKESF 収入
Akeso, Inc.
$15.47
-0.19%
$-0.02
終値： Jan 16, 16:00:00 GMT-5
$15.47
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$15.5
始値
$15.53
当日レンジ
$15.47 - $16.1
52週レンジ
$6.81 - $23.15
取引高
--
平均取引高
1.1K
1株当たり利益(TTM)
-0.14
配当利回り
--
時価総額
$14.2B
AKESO INC.とは何ですか？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.